Patent · US Expired

Light-induced killing of carcinoma cells

US4651739A · kind A · utility

30Cited by
3References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 8, 1985
Grant dateMar 24, 1987
Priority date
Expiry dateApr 8, 2005

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of killing carcinoma cells associated normal cells using light of a predetermined wavelength. The method includes contacting the cells with a chromophor at a given concentration. The chromophor is positively charged and sufficiently lipophilic to be taken up by the mitochondria of the carcinoma cells and is retained substantially longer in the mitochondria of carcinoma cells than in normal cell mitochondria; or it may be taken up in greater quantity by the carcinoma cells than by the normal cells. The chromophor must also have a therapeutic index for light-induced cell killing of at least 500 for light of the predetermined wavelength, and has a therapeutic ratio for light-induced killing of at least 50 for light of said pre-determined wavelength. The cells are then exposed to light of this wavelength.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.